2/18/2013

Aurobindo Pharma received FDA approval to market its pioglitazone tablets in three strengths and its pioglitazone hydrochloride and metformin hydrochloride tablets in two doses. Both drugs are indicated as added therapy, alongside exercise and diet, to assist with glycemic control in patients with type 2 diabetes.

Related Summaries